Clinical Trial

Safety & Efficacy of IR-101 in Relapsed/Refractory Neuroblastoma

Name: Safety & Efficacy of IR-101 in Relapsed/Refractory Neuroblastoma — clinical trial record (NCT07067346)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Early Phase 1

View on ClinicalTrials.gov →

Record status

This record was last updated July 29, 2025 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.

Summary

Radiopharmaceutical in Relapsed/Refractory Neuroblastoma

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-07-14.

Trial Details

NCT Number	NCT07067346
Lead Sponsor	Sichuan University
Conditions	Neuroblastoma
Enrollment	10 participants
Start Date	2025-07-18
Primary Completion	2026-06-30 (estimated)
Study Completion	2026-06-30 (estimated)
Updated on ClinicalTrials.gov	2025-07-29